{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782969",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782969_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"acetazolamide\" outputclass=\"int-drug\">Acetazolamide</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Acetazolamide   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acetazolamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782970",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782970_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">Carbamazepine</ph> <ph outputclass=\"int-magnitude\">slightly to moderately</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph> and <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph> <ph outputclass=\"int-effect\">affects</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">carbamazepine</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Carbamazepine   slightly to moderately   decreases   the concentration of   zonisamide  and  zonisamide   affects   the concentration of   carbamazepine .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carbamazepine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782971",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782971_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"clomipramine\" outputclass=\"int-drug\">Clomipramine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Clomipramine   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clomipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782972",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782972_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"fosphenytoin\" outputclass=\"int-drug\">Fosphenytoin</ph> <ph outputclass=\"int-magnitude\">slightly to moderately</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Fosphenytoin   slightly to moderately   decreases   the concentration of   zonisamide .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fosphenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782973",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782973_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"haloperidol\" outputclass=\"int-drug\">Haloperidol</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Haloperidol   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Haloperidol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782974",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782974_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydroxyzine\" outputclass=\"int-drug\">Hydroxyzine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Hydroxyzine   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydroxyzine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782975",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782975_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"imipramine\" outputclass=\"int-drug\">Imipramine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Imipramine   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Imipramine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782976",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782976_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"oxybutynin\" outputclass=\"int-drug\">Oxybutynin</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oxybutynin   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxybutynin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782977",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782977_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"phenobarbital\" outputclass=\"int-drug\">Phenobarbital</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Phenobarbital   is predicted to   decrease   the concentration of   zonisamide .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenobarbital</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782978",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782978_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"phenytoin\" outputclass=\"int-drug\">Phenytoin</ph> <ph outputclass=\"int-magnitude\">slightly to moderately</ph> <ph outputclass=\"int-effect\">decreases</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Phenytoin   slightly to moderately   decreases   the concentration of   zonisamide .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782979",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782979_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"primidone\" outputclass=\"int-drug\">Primidone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises monitor and adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Primidone   is predicted to   decrease   the concentration of   zonisamide .  Manufacturer advises monitor and adjust dose .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Primidone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782980",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2#bnf_i1557280782980_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"topiramate\" outputclass=\"int-drug\">Topiramate</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of overheating and dehydration when given with</ph> <ph otherprops=\"zonisamide\" outputclass=\"int-heading-drug\">zonisamide</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid in children</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Topiramate   potentially   increases   the risk of overheating and dehydration when given with   zonisamide .  Manufacturer advises avoid in children .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Topiramate</title>"
					}
				}
			],
			"hasSearchLabel": " Zonisamide  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/zonisamide-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Zonisamide </title>"
			},
			"rdfs:label": "zonisamide"
		}
	]
}